Loading chat...
IN HB1248
Bill
Status
5/5/2019
Primary Sponsor
Steven Davisson
Click for details
AI Summary
-
Pharmacists may provide emergency refills of non-controlled prescription medications for up to 30 days (or the most recent fill quantity, whichever is less) when unable to contact the prescriber, limited to one emergency refill per prescription in a six-month period.
-
Pharmacists gain authority to prescribe FDA-approved devices and supplies including nebulizers, CPAP supplies, insulin pump supplies, diabetes testing supplies, pen needles, syringes, and wound care saline/sterile water, with required advance beneficiary notice kept on file for seven years.
-
Pharmacists may adapt prescriptions (excluding controlled substances, compounded drugs, and biologicals) by changing quantity, dosage form, completing missing information, or extending maintenance drugs for medication synchronization, with patient consent and documentation required.
-
Physician assistant oversight changes from "supervising physician" to "collaborating physician" model, with collaboration defined as overseeing activities and accepting responsibility while being immediately available through telecommunications when not physically present.
-
Requirements removed for physician assistants include: 1,800 hours of practice before prescribing controlled substances, 30-day supply limits on controlled substances, 25% first-year chart review, and mandatory 30 contact hours in pharmacology education; chart review reduced to 10% for prescribing-related records in first year of prescriptive authority.
Legislative Description
Pharmacists; physician assistants. Sets out the conditions for emergency pharmaceutical refills and prescription adaptations. Permits a pharmacist to prescribe certain devices or supplies approved by the federal Food and Drug Administration. Provides that if a pharmacist prescribes certain devices or supplies, the pharmacist must provide the patient with a written advance beneficiary notice that is signed by the patient and that states that the patient may not be eligible for reimbursement for the device or supply. Requires that the pharmacy must keep a copy of the patient's advance beneficiary notice. Changes the role of a supervising physician for a physician assistant to that of a collaborating physician. Removes prescribing requirement language of at least 30 contact hours in pharmacology by a program approved by the committee and requires the physician assistant to have graduated from an accredited physician assistant program and have received the required pharmacology training from the program. Removes the following requirements concerning prescribing by a physician assistant: (1) A physician assistant prescribing a controlled substance to have practiced as a physician assistant for at least 1,800 hours. (2) Prescribing authority being delegated to a physician assistant to be expressly delegated in writing by the physician. (3) Limiting the amount prescribed to an amount not to exceed a 30 day supply. Removes a requirement that a physician review at least 25% of the patient's records in a physician assistant's first year of practice. Requires the review of at least 10% of the patient records concerning the prescribing or administering of a drug (instead of only certain scheduled drugs) for the first year in which a physician assistant obtains authority to prescribe a drug. Removes certain chart review requirements and a statement to the board by the physician.
Last Action
Public Law 247
5/5/2019